查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108203

聚合酵素鏈鎖反應(PCR) 市場分析與預測（至 2035 年）：類型、產品類型、服務、技術、組件、應用、製程、最終用戶、解決方案、交付形式

Polymerase Chain Reaction Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, End User, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球聚合酵素鏈鎖反應( PCR) 市場預計將從 2025 年的 152 億美元成長到 2035 年的 280 億美元，複合年成長率 (CAGR) 為 6.4%。 PCR 市場集中度適中，領先的生命科學和分子診斷公司專注於擴展其 PCR 平台、檢測產品組合和自動化能力。市場成長的驅動力來自對分子診斷、傳染病檢查、癌症研究、基因分析和精準醫療日益成長的需求。數位 PCR、即時PCR和自動化工作流程解決方案的持續創新，以及策略聯盟和新產品的推出，加劇了市場競爭。例如，QIAGEN 於 2025 年 1 月推出了 QIAcuity 高通量探針 PCR 試劑盒和 QIAcuity 軟體 3.1，將其數位 PCR 平台的多重偵測能力從 5 個標靶擴展到 12 個標靶。這使得更精細的生物學分析成為可能，並提高了分子研究的效率。

從產品細分來看，試劑和耗材領域在2025年聚合酵素鏈鎖反應（PCR）市場中佔主導地位。這是因為這些產品在所有PCR工作流程中反覆使用，涵蓋臨床診斷、研究、藥物開發和生物技術應用等領域。 PCR試劑，包括酵素、引子、探針、核苷酸和緩衝液，需要頻繁補充，從而產生了來自全球實驗室的持續需求。分子診斷測試數量的增加、基因組研究的擴展以及基於PCR的感染疾病和癌症檢測的日益普及，進一步鞏固了該領域的主導地位。持續的產品創新、檢測性能的提升以及對生命科學研究投入的增加，將繼續支持試劑和耗材在全球PCR市場的主導地位。

市場區隔
種類 常規PCR、即時PCR、數位PCR及其他
產品 設備、試劑/耗材、軟體及其他
服務 校準服務、維護服務、訓練服務等。
科技 聚合酵素連鎖反應熱迴圈儀、qPCR、dPCR 等
成分 酵素、引子、緩衝液、核苷酸及其他
目的 臨床診斷、調查、法醫學、環境檢測、食品安全等。
過程 擴增、定量、檢測及其他
最終用戶 醫院和診斷中心、學術和研究機構、製藥和生物技術公司、臨床研究機構等。
解決方案 獨立式PCR系統、整合系統及其他
模式 全自動、半自動、手動、其他

按類型分類，數位PCR預計將在預測期內實現最快成長，這主要得益於其相比傳統PCR和即時PCR技術更高的靈敏度、更精確的核酸定量能力和卓越的分析準確性。數位PCR正日益廣泛應用於腫瘤診斷、液態生物檢體、罕見突變檢測、傳染病檢查以及細胞和基因治療研究等領域，在這些領域，高精確度分子分析至關重要。對精準醫療日益成長的需求、臨床診斷應用範圍的擴大以及對先進分子檢測投入的增加，都在加速數位PCR的普及。持續的技術創新、工作流程自動化以及檢測能力的提升，預計將在整個預測期內進一步推動數位PCR領域的快速成長。

區域概覽

2025年，北美在聚合酵素鏈鎖反應（PCR）市場主導，這得益於其先進的醫療基礎設施、強大的分子診斷生態系統以及對基因組學和生命科學研究的大量投資。該地區受益於主要PCR技術供應商的存在、成熟的診斷實驗室以及PCR檢測在臨床診斷、感染疾病檢測、腫瘤學和基因檢測領域的廣泛應用。美國佔最大的區域市場佔有率，這主要歸功於其高額的醫療保健支出、政府對生物醫學研究的大量資助、對精準醫療日益成長的需求，以及製藥、生物技術和學術研究機構對先進PCR平台的廣泛應用。加拿大則透過擴大基因組學研究和支持性醫療政策，進一步推動了市場發展。

預計亞太地區將在預測期內實現最快成長，這主要得益於醫療基礎設施的快速擴張、分子診斷技術的日益普及以及生物技術和基因組學研究投資的不斷成長。中國、印度、日本和韓國等國家在臨床診斷、精準醫療和感染疾病監測方面的投資顯著增加，加速了先進PCR技術的需求。政府對醫療現代化的大力支持、製藥和生物技術產業的擴張、研究活動的活性化以及人們對疾病早期診斷意識的提高，都進一步推動了市場成長。此外，診斷檢查室的擴建和先進醫療服務的普及預計將在整個預測期內鞏固該地區的PCR市場。

主要趨勢和促進因素

數位PCR和先進分子診斷技術的應用日益廣泛：

在聚合酵素鏈鎖反應(PCR) 市場，由於數位 PCR (dPCR) 和先進分子診斷技術具有卓越的靈敏度、準確性和核酸絕對定量能力，其應用正迅速發展。數位 PCR 的應用日益廣泛，涵蓋腫瘤學、感染疾病檢測、液態生物檢體、基因檢測以及細胞和基因治療研究等領域。自動化、多重化和整合 PCR 平台的不斷進步正在提升工作流程效率和診斷準確性。此外，精準醫療和疾病早期檢測的日益普及也加速了先進 PCR 技術在全球臨床診斷和生物醫學研究中的應用。

對分子診斷和精準醫療日益成長的需求：

分子診斷和精準醫療需求的不斷成長是聚合酵素鏈鎖反應(PCR) 市場的主要驅動力。隨著感染疾病、癌症和遺傳性疾病的日益流行，對快速、準確和高靈敏度的診斷解決方案的需求也日益成長。 PCR 技術在疾病診斷、病原體檢測、生物標記鑑定和基因分析中發揮著至關重要的作用，使其成為現代醫學不可或缺的一部分。此外，基因組研究投入的增加、製藥和生物技術活動的拓展以及政府對先進診斷基礎設施的大力支持，都進一步加速了 PCR 技術在臨床和研究應用中的普及。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 常規PCR
    • 即時PCR
    • 數位PCR
    • 其他
  • 市場規模及預測：依產品分類
    • 裝置
    • 試劑和耗材
    • 軟體
    • 其他
  • 市場規模及預測：依服務分類
    • 校對服務
    • 維護服務
    • 培訓服務
    • 其他
  • 市場規模及預測：依技術分類
    • 聚合酵素連鎖反應熱迴圈儀
    • qPCR
    • dPCR
    • 其他
  • 市場規模及預測：依應用領域分類
    • 臨床診斷
    • 研究
    • 法醫學
    • 環境測試
    • 食品安全
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院和診斷中心
    • 學術和研究機構
    • 製藥和生物技術公司
    • 臨床研究機構
    • 其他
  • 市場規模及預測：依製程分類
    • 放大
    • 定量分析
    • 偵測
    • 其他
  • 市場規模及預測：依組件分類
    • 酵素
    • 底漆
    • 緩衝
    • 核苷酸
    • 其他
  • 市場規模及預測：按解決方案分類
    • 獨立式PCR系統
    • 整合系統
    • 其他
  • 市場規模及預測：按模式
    • 自動化
    • 半自動
    • 手動的
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • QIAGEN
  • Agilent Technologies
  • Takara Bio
  • Merck KGaA
  • Illumina
  • PerkinElmer
  • Becton Dickinson
  • Promega Corporation
  • Eppendorf
  • Analytik Jena
  • Fluidigm Corporation
  • LGC Limited
  • Abbott Laboratories
  • Danaher Corporation
  • Biomerieux
  • GE Healthcare
  • Cepheid

第9章 關於我們

簡介目錄
Product Code: GIS21239

The global Polymerase Chain Reaction Market is projected to grow from $15.2 billion in 2025 to $28.0 billion by 2035, at a compound annual growth rate (CAGR) of 6.4%. The Polymerase Chain Reaction (PCR) Market is moderately consolidated, with leading life science and molecular diagnostics companies focusing on expanding PCR platforms, assay portfolios, and automation capabilities. Market growth is driven by increasing demand for molecular diagnostics, infectious disease testing, oncology research, genetic analysis, and precision medicine. Continuous innovation in digital PCR, real-time PCR, and automated workflow solutions, along with strategic collaborations and product launches, is strengthening the competitive landscape. For instance, in January 2025, QIAGEN launched the QIAcuity High Multiplex Probe PCR Kit and QIAcuity Software 3.1, increasing its digital PCR platform's multiplexing capability from five to twelve targets, enabling deeper biological analysis and improving molecular research efficiency.

Based on Product, the Reagents and Consumables segment dominated the Polymerase Chain Reaction (PCR) market in 2025 due to their recurring use in every PCR workflow across clinical diagnostics, research, pharmaceutical development, and biotechnology applications. PCR reagents, including enzymes, primers, probes, nucleotides, and buffers, require frequent replenishment, generating continuous demand from laboratories worldwide. The increasing volume of molecular diagnostic testing, expanding genomics research, and rising adoption of PCR-based infectious disease and oncology testing have further strengthened the segment's leadership. Continuous product innovations, improved assay performance, and growing investments in life sciences research continue to support the dominance of reagents and consumables in the global PCR market.

Market Segmentation
TypeConventional PCR, Real-time PCR, Digital PCR, Others
ProductInstruments, Reagents and Consumables, Software, Others
ServicesCalibration Services, Maintenance Services, Training Services, Others
TechnologyThermal Cyclers, qPCR, dPCR, Others
ComponentEnzymes, Primers, Buffers, Nucleotides, Others
ApplicationClinical Diagnostics, Research, Forensics, Environmental Testing, Food Safety, Others
ProcessAmplification, Quantification, Detection, Others
End UserHospitals and Diagnostic Centers, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Others
SolutionsStandalone PCR Systems, Integrated Systems, Others
ModeAutomated, Semi-automated, Manual, Others

Based on Type, the Digital PCR segment is projected to register the fastest growth during the forecast period, driven by its superior sensitivity, absolute nucleic acid quantification, and exceptional analytical precision compared with conventional and real-time PCR techniques. Digital PCR is increasingly utilized in oncology diagnostics, liquid biopsy, rare mutation detection, infectious disease testing, and cell and gene therapy research, where highly accurate molecular analysis is essential. Rising demand for precision medicine, expanding applications in clinical diagnostics, and increasing investments in advanced molecular testing are accelerating adoption. Continuous technological innovations, workflow automation, and improved assay capabilities are expected to further drive the rapid growth of the Digital PCR segment throughout the forecast period.

Geographical Overview

North America dominated the Polymerase Chain Reaction (PCR) market in 2025, supported by its advanced healthcare infrastructure, strong molecular diagnostics ecosystem, and substantial investments in genomics and life sciences research. The region benefits from the presence of leading PCR technology providers, well-established diagnostic laboratories, and extensive adoption of PCR-based testing across clinical diagnostics, infectious disease detection, oncology, and genetic testing. The United States accounts for the largest regional share owing to high healthcare expenditure, significant government funding for biomedical research, increasing demand for precision medicine, and the widespread use of advanced PCR platforms in pharmaceutical, biotechnology, and academic research institutions. Canada further contributes through expanding genomics research and supportive healthcare initiatives.

Asia-Pacific is projected to register the fastest growth during the forecast period, driven by rapidly expanding healthcare infrastructure, increasing adoption of molecular diagnostics, and growing investments in biotechnology and genomic research. Countries such as China, India, Japan, and South Korea are significantly increasing investments in clinical diagnostics, precision medicine, and infectious disease surveillance, accelerating the demand for advanced PCR technologies. Rising government support for healthcare modernization, expanding pharmaceutical and biotechnology industries, growing research activities, and increasing awareness of early disease diagnosis are further fueling market growth. Additionally, the expansion of diagnostic laboratories and improving access to advanced healthcare services are expected to strengthen the regional PCR market throughout the forecast period.

Key Trends and Drivers

Growing Adoption of Digital PCR and Advanced Molecular Diagnostics:

The Polymerase Chain Reaction (PCR) market is witnessing a strong trend toward the adoption of digital PCR (dPCR) and advanced molecular diagnostic technologies due to their superior sensitivity, precision, and absolute nucleic acid quantification capabilities. Digital PCR is increasingly being utilized in oncology, infectious disease detection, liquid biopsy, genetic testing, and cell and gene therapy research. Continuous advancements in automation, multiplexing, and integrated PCR platforms are improving workflow efficiency and diagnostic accuracy. Furthermore, the growing emphasis on precision medicine and early disease detection is accelerating the integration of advanced PCR technologies into clinical diagnostics and biomedical research worldwide.

Increasing Demand for Molecular Diagnostics and Precision Medicine:

The rising demand for molecular diagnostics and precision medicine is a major driver of the Polymerase Chain Reaction (PCR) market. Increasing prevalence of infectious diseases, cancer, and genetic disorders is driving the need for rapid, accurate, and highly sensitive diagnostic solutions. PCR technologies play a critical role in disease diagnosis, pathogen detection, biomarker identification, and genetic analysis, making them indispensable in modern healthcare. Additionally, growing investments in genomics research, expanding pharmaceutical and biotechnology activities, and increasing government support for advanced diagnostic infrastructure are further accelerating the adoption of PCR technologies across clinical and research applications.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Component
  • 2.9 Key Market Highlights by Solutions
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Conventional PCR
    • 4.1.2 Real-time PCR
    • 4.1.3 Digital PCR
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Reagents and Consumables
    • 4.2.3 Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Calibration Services
    • 4.3.2 Maintenance Services
    • 4.3.3 Training Services
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Thermal Cyclers
    • 4.4.2 qPCR
    • 4.4.3 dPCR
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Clinical Diagnostics
    • 4.5.2 Research
    • 4.5.3 Forensics
    • 4.5.4 Environmental Testing
    • 4.5.5 Food Safety
    • 4.5.6 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals and Diagnostic Centers
    • 4.6.2 Academic and Research Institutions
    • 4.6.3 Pharmaceutical and Biotechnology Companies
    • 4.6.4 Clinical Research Organizations
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Amplification
    • 4.7.2 Quantification
    • 4.7.3 Detection
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Component (2020-2035)
    • 4.8.1 Enzymes
    • 4.8.2 Primers
    • 4.8.3 Buffers
    • 4.8.4 Nucleotides
    • 4.8.5 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Standalone PCR Systems
    • 4.9.2 Integrated Systems
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Automated
    • 4.10.2 Semi-automated
    • 4.10.3 Manual
    • 4.10.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Component
      • 5.2.1.9 Solutions
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Component
      • 5.2.2.9 Solutions
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Component
      • 5.2.3.9 Solutions
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Component
      • 5.3.1.9 Solutions
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Component
      • 5.3.2.9 Solutions
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Component
      • 5.3.3.9 Solutions
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Component
      • 5.4.1.9 Solutions
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Component
      • 5.4.2.9 Solutions
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Component
      • 5.4.3.9 Solutions
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Component
      • 5.4.4.9 Solutions
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Component
      • 5.4.5.9 Solutions
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Component
      • 5.4.6.9 Solutions
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Component
      • 5.4.7.9 Solutions
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Component
      • 5.5.1.9 Solutions
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Component
      • 5.5.2.9 Solutions
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Component
      • 5.5.3.9 Solutions
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Component
      • 5.5.4.9 Solutions
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Component
      • 5.5.5.9 Solutions
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Component
      • 5.5.6.9 Solutions
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Component
      • 5.6.1.9 Solutions
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Component
      • 5.6.2.9 Solutions
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Component
      • 5.6.3.9 Solutions
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Component
      • 5.6.4.9 Solutions
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Component
      • 5.6.5.9 Solutions
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Thermo Fisher Scientific
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bio-Rad Laboratories
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Roche Diagnostics
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 QIAGEN
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Agilent Technologies
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Takara Bio
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Merck KGaA
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Illumina
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 PerkinElmer
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Becton Dickinson
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Promega Corporation
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Eppendorf
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Analytik Jena
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Fluidigm Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 LGC Limited
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Abbott Laboratories
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Danaher Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Biomerieux
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 GE Healthcare
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Cepheid
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us